This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other and unspecified erythematous conditions
L12_ERYTH_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1133 |
4. Check minimum number of eventsNone |
1133 |
5. Include endpointsNone |
1133 |
6. Filter based on genotype QC (FinnGen only) |
1133 |
Control definitions (FinnGen only)
- Control exclude
- L12_URTICARIAERYTHEMA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified erythematous conditions
based on the number of shared cases.
Similar with more cases:
- Other erythematous conditions
- Urticaria and erythema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1133 | 728 | 405 |
| Unadjusted period prevalence (%) | 0.22 | 0.25 | 0.18 |
| Median age at first event (years) | 53.94 | 53.73 | 54.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1015
- Matched controls
- 10148
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L53.9
ICD-10 Finland
Erythematous condition, unspecified
894.0
323.0
694
24
L53.8
ICD-10 Finland
Other specified erythematous conditions
322.1
140.2
139
5
69598
ICD-8 Finland
Erythematous condition, Alii definiti
+∞
106.1
100
*
69599
ICD-8 Finland
Erythematous condition, Other and unspecified
+∞
52.5
50
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
51.1
195
494
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.0
36.5
254
1026
E0000UV
ATC
NA
2.3
33.3
478
2852
L50.9
ICD-10 Finland
Urticaria, unspecified
13.1
31.6
56
45
A46
ICD-10 Finland
Erysipelas
2.9
26.7
183
719
H02AB06
ATC
prednisolone; systemic
2.1
26.4
506
3307
R06AE07
ATC
cetirizine; oral
2.0
22.5
472
3125
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
20.4
147
587
XQ800
NOMESCO Finland
Prick test
3.4
20.2
103
327
D07AC01
ATC
betamethasone; topical
1.9
20.1
373
2331
L50.3
ICD-10 Finland
Dermatographic urticaria
75.0
19.8
22
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.9
18.9
124
466
J01FF01
ATC
clindamycin; systemic
2.0
18.6
294
1719
E000001
ATC
NA
2.1
18.4
241
1302
J01DB01
ATC
cefalexin; oral
2.0
16.7
832
7076
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
16.7
304
1859
L50.8
ICD-10 Finland
Other urticaria
23.5
16.5
23
10
D07AC13
ATC
mometasone; topical
1.9
16.2
311
1932
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
16.0
433
3009
L52
ICD-10 Finland
Erythema nodosum
33.9
15.8
20
6
R60.0
ICD-10 Finland
Localized oedema
2.4
15.7
137
609
H02AB07
ATC
prednisone; oral
2.2
15.4
164
803
R06.0
ICD-10 Finland
Dyspnoea
1.9
15.1
260
1550
R03AC02
ATC
salbutamol; inhalant
1.7
14.7
524
3926
134
Kela drug reimbursment
General erythroderma
+∞
14.6
14
*
R06AX27
ATC
desloratadine; oral
1.9
14.6
273
1673
R50.9
ICD-10 Finland
Fever, unspecified
2.2
14.2
160
801
XQ802
NOMESCO Finland
Epicutan test
3.8
13.5
58
161
R06AE09
ATC
levocetirizine; oral
2.1
13.3
158
811
D07AA02
ATC
hydrocortisone; topical
2.2
13.2
149
745
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
12.8
359
2480
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.5
12.7
60
180
Y0999
ICD-8 Finland
Other specific examinations and investigations
32.5
12.6
16
5
6959X
ICD-9 Finland
Erythematous conditions, Unspecified erythematous condition
+∞
12.5
12
*
A02BC02
ATC
pantoprazole; systemic
1.6
12.4
631
5095
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
12.4
114
520
D07AB08
ATC
desonide; topical
2.3
11.9
119
564
L26
ICD-10 Finland
Exfoliative dermatitis
23.2
11.6
16
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
11.6
284
1877
E9399
ICD-8 Finland
Complications and failures arising in connection with medical procedures (excluding subsequent adverse effects).
11.3
11.6
21
19
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
11.5
320
2192
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
11.4
143
748
Z71.8
ICD-10 Finland
Other specified counselling
1.8
11.4
236
1479
L04AX01
ATC
azathioprine; systemic
3.2
11.3
59
192
T78.4
ICD-10 Finland
Allergy, unspecified
3.2
11.3
60
198
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
11.3
110
516
L50.0
ICD-10 Finland
Allergic urticaria
6.3
11.3
29
47
R51.80
ICD-10 Finland
Headache
2.0
11.1
154
837
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
11.1
179
1029
UJF32
NOMESCO Finland
Coloscopy
1.7
11.0
260
1696
N02BE01
ATC
paracetamol; systemic, rectal
1.8
10.8
846
7511
S21
ICPC
Skin texture symptom/complaint
2.1
10.7
130
670
H04.10
ICD-10 Finland
Dry eye syndrome
2.2
10.4
104
492
A92
ICPC
Allergy/allergic reaction NOS
4.5
10.4
36
83
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.3
10.3
93
419
D02AE01
ATC
carbamide; topical
2.5
10.2
79
329
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.1
10.2
120
610
C01CA24
ATC
epinephrine; parenteral
2.8
10.0
66
249
J02AC01
ATC
fluconazole; systemic
1.6
9.9
385
2848
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
9.9
224
1434
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.2
9.8
104
505
D06BX01
ATC
metronidazole; topical
2.1
9.7
112
566
S18
ICPC
Laceration/cut
1.5
9.6
397
2975
D07AD01
ATC
clobetasol; topical
1.9
9.5
158
915
E000006
ATC
NA
2.4
9.5
80
350
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.4
205
1300
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
9.4
165
977
P01BA02
ATC
hydroxychloroquine; oral
2.3
9.2
88
406
XQ848
NOMESCO Finland
Dermatological photography
4.0
9.1
35
90
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
9.0
96
466
R60.9
ICD-10 Finland
Oedema, unspecified
2.8
8.9
56
206
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
8.9
198
1259
M79.6
ICD-10 Finland
Pain in limb
1.5
8.9
349
2571
A02BC05
ATC
esomeprazole; systemic
1.5
8.9
380
2857
L17
ICPC
Foot/toe symptom/complaint
1.6
8.9
241
1621
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
8.8
93
452
R06AX22
ATC
ebastine; oral
1.8
8.8
167
1012
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
8.8
202
1295
J01MA02
ATC
ciprofloxacin; systemic
1.5
8.7
357
2655
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.4
8.6
74
325
A02BC03
ATC
lansoprazole; oral
1.6
8.4
278
1960
M54.5
ICD-10 Finland
Low back pain
1.6
8.3
301
2169
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
8.3
104
543
A02BA02
ATC
ranitidine; systemic
1.7
8.3
193
1240
N02AX02
ATC
tramadol; systemic, rectal
1.5
8.2
391
2994
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
6.6
8.2
20
31
N05BA01
ATC
diazepam; systemic, rectal
1.9
8.2
131
748
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
5.7
8.2
22
39
H02AB04
ATC
methylprednisolone; systemic
1.8
8.1
143
846
S29
ICPC
Skin symptom/complaint other
1.8
8.1
156
948
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.7
8.1
52
196
N06AX11
ATC
mirtazapine; oral
1.6
8.1
287
2057
R02
ICPC
Shortness of breath/dyspnoea
1.9
7.9
116
643
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
7.8
107
579
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.8
77
364
N05BA04
ATC
oxazepam; oral
1.6
7.8
227
1549
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
7.8
169
1065
J01MA12
ATC
levofloxacin; systemic
1.7
7.7
171
1084
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
18.5
7.6
11
6
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.8
7.6
48
179
N03AX12
ATC
gabapentin; oral
1.7
7.6
151
926
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.5
190
1252
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.2
7.4
37
119
A07AA02
ATC
nystatin; oral
2.3
7.4
66
298
C07AB07
ATC
bisoprolol; oral
1.5
7.4
414
3262
R03DC03
ATC
montelukast; oral
1.7
7.4
151
936
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.3
187
1232
A04
ICPC
Weakness/tiredness general
1.8
7.3
119
684
L71.9
ICD-10 Finland
Rosacea, unspecified
4.0
7.3
27
68
C03CA01
ATC
furosemide; systemic
1.5
7.3
250
1771
J01DA01
ATC
[U] cefalexin; systemic
1.4
7.3
600
5087
L20.0
ICD-10 Finland
Besnier prurigo
2.3
7.2
63
283
J01FA10
ATC
azithromycin; systemic
1.4
7.2
537
4464
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
7.2
125
736
J01MA14
ATC
moxifloxacin; systemic
2.0
7.1
92
488
L50.1
ICD-10 Finland
Idiopathic urticaria
20.2
7.1
10
5
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.2
7.0
69
326
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
7.0
201
1360
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.0
7.0
16
23
R07.3
ICD-10 Finland
Other chest pain
1.9
7.0
98
534
N05BB01
ATC
hydroxyzine; systemic
2.2
7.0
66
307
S97
ICPC
Chronic ulcer skin
2.4
6.9
55
234
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
6.9
196
1325
L28
ICPC
Limited function/disability (L)
1.7
6.9
139
857
K30
ICD-10 Finland
Functional dyspepsia
1.9
6.9
105
593
R01AD09
ATC
mometasone; nasal
1.4
6.9
411
3267
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
6.8
388
3052
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
6.8
203
1387
M25.5
ICD-10 Finland
Pain in joint
1.5
6.8
259
1876
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
6.2
6.8
17
28
P29
ICPC
Psychological sympt/compl other
2.4
6.7
53
224
D01
ICPC
Abdominal pain/cramps general
1.9
6.7
103
582
D02AX
ATC
Other emollients and protectives
2.9
6.6
38
134
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
6.5
154
994
E000002
ATC
NA
1.8
6.5
107
620
J01FA06
ATC
roxithromycin; oral
1.4
6.5
372
2926
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
6.4
159
1034
KMAK
NOMESCO Finland
NA
1.4
6.4
464
3810
R4110
NOMESCO Finland
Physiotherapy
1.5
6.3
242
1751
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
6.3
73
371
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
6.3
25
68
69590
ICD-8 Finland
Erythematous condition, Erythema chronicum migrans
+∞
6.3
6
*
6958X
ICD-9 Finland
Erythematous conditions, Other specified erythematous conditions[CASUS ERYTHEMATODES ALIA DEFINITA]
+∞
6.3
6
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
6.2
36
129
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.9
6.2
90
500
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
6.2
78
411
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
6.2
114
682
E000007
ATC
NA
2.2
6.1
58
271
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
6.1
73
376
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.0
401
3228
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
159
605
2.89
30.21
2.5
2.4
15.2
18.3
au/ml
—
6
31
741
5372
2.10
29.96
12.1
9.0
4.1
4.1
e9/l
0.03
658
4702
97
276
3.75
29.61
2.0
1.5
1.2
1.2
g/l
1.48
92
261
94
263
3.81
29.39
2.1
1.6
0.2
0.2
g/l
0.22
89
252
147
545
2.95
29.25
1.4
1.3
23.6
40.2
au/ml
—
6
32
639
4584
1.90
24.32
7.8
6.7
1.2
1.2
mmol/l
0.04
569
3884
102
345
3.15
23.70
1.4
1.2
0.2
1.2
u/ml
—
8
28
563
3964
1.84
21.86
6.0
4.7
35.4
35.5
g/l
0.20
534
3691
880
7157
2.03
21.49
10.4
7.3
79.2
78.5
u/l
0.19
842
6704
850
6860
1.96
20.81
5.9
4.1
12.8
12.2
mm/h
0.49
809
6330
578
4163
1.79
20.27
7.0
5.9
1.2
1.2
mmol/l
0.50
548
3762
192
969
2.18
19.51
4.0
4.2
234.1
251.1
u/l
0.89
181
918
144
654
2.38
18.77
1.7
1.5
—
—
—
0
0
411
2726
1.80
18.64
2.6
2.1
212.2
244.1
u/l
0.16
398
2572
761
6095
1.76
17.08
6.0
4.4
11892.0
3165.4
e6/l
—
5
86
629
4790
1.70
16.87
7.5
6.1
11.3
11.2
umol/l
0.12
602
4540
143
691
2.22
16.04
3.0
2.9
10.4
10.5
g/l
0.10
134
634
604
4590
1.68
15.98
5.0
3.7
0.0
0.0
estimate
0.41
106
816
597
4524
1.68
15.96
4.9
3.6
0.0
0.0
estimate
0.00
104
837
431
2998
1.71
15.93
4.3
3.2
30.2
31.9
u/l
0.58
412
2851
598
4543
1.67
15.75
6.7
5.0
0.0
0.0
estimate
0.50
109
847
166
859
2.09
15.63
2.1
2.0
340.5
373.2
nmol/l
1.39
156
787
204
1141
1.96
15.46
2.7
2.3
103.8
122.4
ug/g
0.56
166
911
344
2288
1.72
14.75
3.1
2.6
2435.4
6867.4
umol/l
1.74
295
1980
315
2048
1.75
14.64
2.1
1.7
1.4
1.2
mg/l
0.38
234
1557
410
2879
1.66
14.25
3.2
2.5
53.3
57.3
u/l
1.79
381
2651
260
1611
1.80
14.21
1.3
1.3
21.4
30.5
iu/ml
0.85
74
519
76
292
2.72
14.00
2.4
1.8
—
—
—
0
0
365
2505
1.67
13.75
3.7
3.0
0.3
0.5
e6/l
1.71
278
1897
503
3744
1.62
13.71
2.3
2.0
92.9
96.1
pmol/l
0.85
266
1911
239
1482
1.78
12.90
1.9
1.8
—
—
—
0
0
528
4016
1.59
12.89
3.6
2.7
119.0
119.8
ug/l
0.03
494
3690
64
237
2.80
12.65
1.4
1.2
2.5
2.6
u/ml
—
6
28
334
2282
1.66
12.61
3.0
2.1
2.8
3.0
mg/l
1.08
291
1936
439
3209
1.60
12.60
3.7
3.5
2.4
2.4
mmol/l
0.06
395
2803
243
1527
1.75
12.49
2.8
2.7
1.1
1.2
e6/l
0.11
137
866
64
241
2.75
12.26
1.5
1.2
27.8
8.6
u/ml
—
9
44
511
3893
1.57
12.15
2.8
2.3
75.8
77.5
nmol/l
0.71
480
3479
1021
9246
2.05
11.99
23.1
13.8
21.1
23.4
mg/l
1.67
885
7274
54
190
2.93
11.73
1.4
1.2
57.1
36.1
u/ml
—
8
17
658
5341
1.55
11.57
6.2
4.7
6.5
6.7
mmol/l
1.12
630
4969
276
1839
1.66
11.31
1.6
1.5
2.2
2.4
g/l
0.95
170
1130
152
853
1.90
11.23
2.3
2.1
0.2
0.2
g/l
0.02
146
803
844
7279
1.63
11.19
4.9
4.0
14.9
14.8
pmol/l
0.54
791
6621
111
558
2.10
11.19
1.3
1.2
262.3
234.3
u/ml
0.09
100
509
225
1431
1.71
10.95
3.0
2.9
4.0
2.9
e6/l
0.56
117
777
705
5852
1.54
10.88
3.3
3.0
—
—
—
0
0
263
1748
1.66
10.83
4.6
3.7
220.6
353.5
ng/l
0.51
198
1345
217
1380
1.71
10.53
2.5
2.1
30.0
29.6
s
0.40
210
1333
717
6019
1.52
10.13
4.1
3.1
49.9
46.6
u/l
0.43
673
5596
173
1047
1.77
9.97
1.8
1.8
—
—
—
0
0
132
736
1.90
9.92
2.7
2.8
66.9
66.5
g/l
0.22
126
671
171
1038
1.76
9.75
1.7
1.8
—
—
—
0
0
447
3429
1.50
9.63
4.7
3.6
42.0
44.3
ng/l
0.05
311
2345
954
8588
1.70
9.61
6.0
4.8
1.8
2.1
mu/l
0.81
898
7854
251
1694
1.62
9.60
1.8
1.7
1080.4
1182.8
nmol/l
1.28
201
1268
85
409
2.17
9.59
1.6
2.1
37.2
39.0
u/l
0.42
78
365
71
318
2.32
9.51
2.6
2.3
2.9
3.2
g/l
1.58
53
250
193
1221
1.70
9.48
6.4
5.5
1.0
1.0
mmol/l
0.37
181
1117
67
293
2.37
9.48
2.4
2.5
1.3
1.0
g/l
0.21
59
258
354
2595
1.53
9.42
3.3
3.0
1516.0
1236.4
ng/l
0.72
306
2200
168
1025
1.75
9.40
3.1
2.9
9.5
7.8
umol/l
0.39
140
891
199
1277
1.68
9.25
2.6
2.4
2.4
2.3
g/l
0.43
185
1187
61
259
2.43
9.21
2.5
2.3
0.2
0.0
g/l
0.54
56
239
73
338
2.24
9.06
2.6
2.2
3.5
3.8
g/l
0.69
53
246
73
339
2.23
9.00
2.6
2.2
7.1
7.4
g/l
0.82
56
258
73
339
2.23
9.00
2.6
2.2
—
—
—
0
0
230
1543
1.62
8.96
1.3
1.2
11.1
12.8
u/ml
0.14
80
602
130
746
1.84
8.91
2.2
3.0
180.5
195.6
ng/l
0.17
121
688
211
1399
1.62
8.59
2.6
2.4
12.8
12.9
umol/l
0.11
197
1291
186
1195
1.67
8.58
2.8
2.4
22.1
22.8
%
0.30
151
1018
283
2019
1.54
8.39
4.8
4.0
1.0
1.0
kg/l
0.72
69
300
268
1898
1.54
8.19
3.1
2.5
3.7
6.4
e6/l
4.01
238
1671
62
285
2.24
7.85
1.6
1.6
0.8
0.1
iu/ml
0.43
12
61
1024
9513
1.79
7.80
24.2
15.9
139.5
139.7
mmol/l
1.24
1010
9256
25
71
3.58
7.72
1.3
1.2
—
—
—
0
0
25
71
3.58
7.72
1.3
1.2
—
—
—
0
0
214
1464
1.57
7.58
4.4
3.4
0.8
0.8
mmol/l
0.79
197
1364
63
296
2.19
7.58
2.1
1.6
—
—
—
0
0
55
244
2.32
7.58
2.5
2.3
0.0
0.0
g/l
0.00
50
226
25
72
3.53
7.57
1.3
1.2
—
—
—
0
0
25
72
3.53
7.57
1.3
1.2
—
—
—
0
0
25
72
3.53
7.57
1.3
1.2
—
—
—
0
0
55
246
2.30
7.44
2.5
2.3
0.0
0.0
g/l
0.00
50
227
1024
9538
1.77
7.39
24.6
16.0
4.0
4.0
mmol/l
0.50
1009
9264
76
390
2.02
7.28
1.5
2.0
1.4
1.5
g/l
0.60
66
341
16
34
4.76
7.18
1.8
1.4
9.9
8.7
ug/l
0.27
16
34
233
1643
1.53
7.17
1.6
1.5
—
—
—
0
0
42
169
2.54
7.15
3.3
3.8
3.9
4.0
e9/l
0.16
42
169
43
176
2.50
7.07
3.5
4.0
57.1
57.6
%
0.08
43
176
285
2101
1.48
7.06
1.4
1.3
1.7
1.5
u/ml
0.10
70
558
520
4282
1.40
6.96
5.3
4.0
—
—
—
0
0
136
853
1.68
6.83
2.4
2.2
36.4
34.6
u/l
0.11
122
720
39
155
2.57
6.82
1.5
1.7
—
—
—
0
0
41
168
2.49
6.74
1.1
1.2
—
—
—
0
0
929
8494
1.52
6.73
23.9
15.0
39.1
39.5
%
0.72
660
6092
56
264
2.18
6.71
2.3
2.7
192.6
186.6
%
0.18
50
252
289
2159
1.45
6.64
1.7
1.5
20.1
21.2
nmol/l
0.71
257
1827
44
189
2.38
6.55
1.3
1.3
—
—
—
0
0
44
189
2.38
6.55
1.3
1.3
—
—
—
0
0
435
3503
1.39
6.53
5.4
3.9
—
—
—
0
0
63
315
2.06
6.50
2.7
2.3
11.4
10.2
g/l
0.87
54
269
57
275
2.13
6.45
1.4
1.4
297.6
291.1
ug/g
0.08
34
163
18
46
3.96
6.45
1.1
1.1
—
—
—
0
0
1044
9839
1.78
6.40
15.0
10.2
25.7
25.5
u/l
0.17
1023
9482
23
71
3.29
6.30
1.3
1.1
391.3
85.5
titre
—
8
11
27
92
2.98
6.30
1.2
1.3
—
—
—
0
0
47
213
2.26
6.21
1.5
1.7
—
—
—
0
0
35
139
2.57
6.15
1.3
1.2
1.5
2.4
u/ml
—
10
34
56
274
2.10
6.13
2.5
2.2
38.5
37.9
g/l
0.36
50
236
72
388
1.91
6.03
1.4
1.4
24.9
28.4
iu/l
0.36
61
328
238
1743
1.46
6.00
2.9
3.0
2.5
2.5
mmol/l
1.03
215
1541
167
1141
1.54
5.88
27.4
24.1
1.5
1.3
inr
0.72
19
148
13
28
4.69
5.74
1.4
1.1
—
—
—
0
0
63
331
1.96
5.69
2.3
1.8
—
—
—
0
0
47
222
2.17
5.64
1.4
1.5
9.8
10.5
u/l
0.10
39
174
16
42
3.85
5.55
1.1
1.1
1.1
1.1
ratio
—
7
13
358
2852
1.37
5.54
3.6
3.2
7.0
7.3
mmol/l
0.45
308
2403
34
144
2.40
5.27
1.3
1.1
—
—
—
0
0
44
209
2.15
5.23
1.5
1.7
—
—
—
0
0
119
773
1.60
5.21
7.5
7.6
9.6
9.5
mmol/l
0.06
113
740
849
7764
1.37
5.00
27.8
16.9
13.8
13.7
%
1.15
839
7586
53
278
1.95
4.85
1.2
1.2
—
—
—
0
0
20
67
3.02
4.84
1.7
1.6
—
—
—
0
0
41
196
2.13
4.81
1.4
1.6
3.9
14.4
e6/l
1.07
32
154
41
196
2.13
4.81
1.5
1.7
1429.4
796.5
e6/l
0.17
35
158
33
144
2.33
4.81
1.4
1.2
3.2
6.6
u/ml
0.59
15
59
53
279
1.94
4.80
1.2
1.2
—
—
—
0
0
280
2194
1.37
4.70
3.5
2.3
—
—
—
0
0
36
165
2.22
4.69
1.4
1.7
—
—
—
0
0
127
859
1.54
4.68
5.4
3.6
1.7
1.9
mmol/l
0.35
112
687
147
1026
1.50
4.68
1.6
1.7
1.4
1.5
%
0.27
127
910
145
1010
1.50
4.66
6.9
8.0
1.5
1.3
mmol/l
0.21
117
807
17
53
3.24
4.62
2.5
2.6
—
—
—
0
0
20
69
2.93
4.62
1.2
1.0
—
—
—
0
0
144
1006
1.49
4.56
6.9
8.0
12.4
12.2
kpa
0.14
139
965
41
201
2.08
4.53
1.4
1.4
—
—
—
0
0
75
450
1.71
4.48
5.3
3.9
24.1
24.1
mmol/l
0.01
67
416
15
45
3.36
4.33
1.3
2.3
—
—
—
0
0
15
45
3.36
4.33
1.3
2.3
—
—
—
0
0
929
8683
1.39
4.30
20.5
12.7
81.5
80.9
ml/min/173m2
0.36
787
7109
18
61
2.98
4.29
1.6
1.2
—
—
—
0
0
86
542
1.63
4.28
2.5
3.3
4.3
4.5
pmol/l
1.02
76
473
46
242
1.94
4.21
1.8
1.5
—
—
—
0
0
303
2439
1.33
4.20
6.2
4.0
0.0
0.0
estimate
1.08
107
821
15
46
3.29
4.19
1.6
1.5
—
—
—
0
0
18
62
2.93
4.18
1.6
1.2
—
—
—
0
0
29
128
2.30
4.15
1.4
1.5
—
—
—
0
0
20
74
2.73
4.10
1.2
1.1
25.3
37.9
mg/l
1.38
15
60
86
549
1.61
4.08
1.7
1.7
—
—
—
0
0
15
47
3.22
4.06
1.6
1.5
—
—
—
0
0
134
945
1.47
4.06
3.5
4.1
16.0
28.3
ug/l
0.36
113
772
17
58
2.96
4.02
2.5
2.5
10.6
13.6
%
—
9
30
20
75
2.70
4.00
1.3
1.6
—
—
—
0
0
20
75
2.70
4.00
1.3
1.6
—
—
—
0
0
20
75
2.70
4.00
1.3
1.6
—
—
—
0
0
11
28
3.96
3.98
1.2
1.1
0.3
0.3
g/l
—
6
20
83
531
1.61
3.91
1.7
1.5
—
—
—
0
0
30
139
2.19
3.85
1.4
1.5
—
—
—
0
0
28
126
2.25
3.85
1.6
1.6
—
—
—
0
0
24
101
2.41
3.83
1.6
1.8
—
—
—
0
0
30
140
2.17
3.79
2.2
3.0
654.0
735.0
u/ml
—
5
11
14
44
3.21
3.78
1.2
1.7
—
—
—
0
0
14
44
3.21
3.78
1.2
1.7
—
—
—
0
0
14
44
3.21
3.78
1.2
1.7
—
—
—
0
0
14
44
3.21
3.78
1.2
1.7
—
—
—
0
0
49
274
1.82
3.76
3.5
3.5
93.9
73.4
mg/l
0.16
40
220
49
274
1.82
3.76
3.5
3.5
29.6
40.1
mg/l
0.43
39
221
27
122
2.24
3.69
1.4
1.5
—
—
—
0
0
46
254
1.85
3.68
1.3
1.3
—
—
—
0
0
49
278
1.80
3.60
1.8
2.0
126.0
2490.8
u/l
—
8
104
14
46
3.07
3.53
1.1
1.3
—
—
—
0
0
976
9266
1.38
3.52
5.4
4.8
2.7
2.8
mmol/l
1.15
915
8532
6
6
10.04
3.50
3.5
1.2
—
—
—
0
0
1068
10318
1.61
3.49
32.9
20.3
253.9
253.0
e9/l
0.18
1055
10055
1068
10322
1.60
3.43
32.8
20.3
4.4
4.5
e12/l
1.26
1056
10031
16
58
2.78
3.43
1.6
1.4
—
—
—
0
0
1068
10324
1.60
3.40
33.2
20.4
133.5
134.7
g/l
1.85
1062
10168
1068
10324
1.60
3.40
32.8
20.3
6.8
6.7
e9/l
0.90
1055
10035
24
107
2.27
3.40
1.3
1.2
—
—
—
0
0
10
27
3.73
3.36
1.4
1.1
—
—
—
0
0
944
8935
1.34
3.32
5.0
4.5
6.0
5.9
mmol/l
0.41
880
8132
954
9044
1.35
3.31
4.8
4.3
1.5
1.5
mmol/l
1.32
899
8335
334
2803
1.27
3.28
4.0
4.0
9.7
9.1
mg/mmol
0.09
198
1728
32
163
1.99
3.26
1.4
1.5
—
—
—
0
0
44
250
1.79
3.24
1.3
1.3
—
—
—
0
0
18
72
2.52
3.22
1.6
1.3
—
—
—
0
0
22
97
2.29
3.21
1.9
1.7
—
—
—
0
0
39
215
1.84
3.17
1.7
1.7
41.3
39.5
nmol/l
0.17
39
205
43
245
1.78
3.15
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
44
2.98
3.14
1.1
1.2
—
—
—
0
0
35
187
1.90
3.13
2.4
2.1
133.3
129.2
g/l
0.36
24
143
924
8739
1.31
3.11
4.3
3.9
1.3
1.3
mmol/l
0.53
862
7995
957
9096
1.34
3.11
4.9
4.4
4.6
4.7
mmol/l
2.14
904
8430
23
105
2.22
3.10
1.0
1.1
—
—
—
0
0
58
361
1.64
3.10
2.2
1.9
—
—
—
0
0
5
5
10.04
2.98
1.2
1.0
1.8
1.0
u/field
—
5
5
20
88
2.30
2.95
2.0
1.8
—
—
—
0
0
22
101
2.20
2.94
1.0
1.1
—
—
—
0
0
13
46
2.85
2.92
3.0
1.9
109.1
72.5
ug/l
0.34
13
46
74
496
1.53
2.91
1.2
1.3
—
—
—
0
0
10
30
3.35
2.91
3.8
4.7
—
—
—
0
0
892
8420
1.28
2.90
6.5
5.7
39.8
39.8
mmol/mol
0.04
839
7795
15
58
2.61
2.88
1.5
1.6
—
—
—
0
0
27
136
2.01
2.87
1.2
1.1
—
—
—
0
0
12
41
2.95
2.86
1.1
1.0
—
—
—
0
0
105
758
1.42
2.86
3.8
3.8
83.5
81.4
ng/l
0.09
90
667
53
330
1.64
2.85
2.3
1.7
—
—
—
0
0
24
116
2.09
2.84
1.8
1.3
—
—
—
0
0
45
269
1.70
2.82
1.3
1.3
226.5
225.8
miu/ml
0.00
13
125
45
270
1.69
2.79
1.4
1.2
—
—
—
0
0
12
42
2.88
2.75
1.3
2.2
24.2
218.4
ug/l
0.47
12
35
56
357
1.60
2.75
1.8
2.0
2.7
2.2
ug/l
0.14
45
317
38
218
1.77
2.75
1.6
1.7
39210.5
15446.9
e6/l
0.40
24
163
15
60
2.52
2.71
1.1
1.1
1.0
1.1
u/l
—
5
29
8
19
4.23
2.68
1.3
1.7
—
—
—
0
0
48
298
1.64
2.63
2.4
4.2
1.3
1.3
mmol/l
0.04
48
291
7
15
4.69
2.60
1.9
1.4
—
—
—
0
0
19
87
2.20
2.58
1.9
1.1
—
—
—
0
0
78
544
1.47
2.57
2.4
2.2
12.5
12.8
nmol/l
0.12
71
480
82
578
1.45
2.56
4.7
3.7
1.7
2.0
mmol/l
0.34
56
443
7
16
4.40
2.47
1.0
1.0
—
—
—
0
0
7
16
4.40
2.47
1.4
1.3
—
—
—
0
0
23
116
2.00
2.47
2.8
2.4
9.8
32.2
mg/l
—
5
32
27
145
1.88
2.43
1.1
1.2
—
—
—
0
0
10
34
2.96
2.41
1.3
1.8
—
—
—
0
0
10
34
2.96
2.41
1.3
1.8
—
—
—
0
0
74
518
1.46
2.40
2.3
1.9
—
—
—
0
0
29
162
1.81
2.32
1.6
1.2
286.5
257.7
u/ml
0.19
17
94
84
607
1.41
2.31
4.7
3.7
5.1
5.2
kpa
0.20
76
574
10
35
2.87
2.30
1.3
1.8
—
—
—
0
0
120
921
1.34
2.29
4.4
3.2
—
—
—
0
0
8
23
3.50
2.27
1.1
1.1
—
—
—
0
0
8
23
3.50
2.27
1.1
1.7
—
—
—
0
0
45
288
1.59
2.22
2.5
2.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
281
1.59
2.20
2.5
2.7
0.3
0.4
u/ml
0.49
19
156
286
2460
1.22
2.15
1.8
1.6
1.4
1.4
mmol/l
0.08
249
2086
31
182
1.72
2.13
1.7
1.6
—
—
—
0
0
12
49
2.46
2.11
1.2
1.1
—
—
—
0
0
232
1963
1.23
2.05
1.8
1.7
465.2
28457221.1
pmol/l
2.06
198
1620
38
241
1.60
1.98
1.4
1.4
—
—
—
0
0
12
51
2.37
1.95
1.3
1.1
—
—
—
0
0
59
415
1.44
1.92
2.1
1.9
—
—
—
0
0
96
734
1.34
1.91
2.1
2.5
7.2
7.4
ug/l
0.05
77
639
27
158
1.73
1.90
1.1
1.1
6.5
2.2
u/ml
—
10
58
22
121
1.83
1.89
1.5
1.4
—
—
—
0
0
22
121
1.83
1.89
1.5
1.4
—
—
—
0
0
22
121
1.83
1.89
1.5
1.4
—
—
—
0
0
259
2238
1.20
1.85
5.3
4.8
2.4
2.5
ug/l
0.07
231
1975
22
122
1.82
1.85
1.5
1.4
—
—
—
0
0
29
175
1.67
1.84
3.6
2.3
16.4
15.9
%
0.25
15
91
120
953
1.29
1.83
2.4
2.0
—
—
—
0
0
22
123
1.80
1.81
1.5
1.4
—
—
—
0
0
22
123
1.80
1.81
1.5
1.4
—
—
—
0
0
29
176
1.66
1.80
1.6
1.2
—
—
—
0
0
109
859
1.30
1.77
2.2
1.9
—
—
—
0
0
18
95
1.91
1.76
1.0
1.1
47.3
53.9
u/l
0.52
13
67
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
17
89
1.92
1.70
1.1
1.1
—
—
—
0
0
24
141
1.72
1.69
4.9
3.2
1.3
1.0
%
0.23
19
116
15
77
1.96
1.59
1.9
2.5
—
—
—
0
0
14
70
2.01
1.59
1.1
1.2
0.0
1.0
u/ml
—
7
29
94
740
1.29
1.56
9.0
3.7
1.2
1.2
mmol/l
0.28
86
636
12
57
2.12
1.55
1.1
1.2
—
—
—
0
0
12
57
2.12
1.55
1.1
1.2
—
—
—
0
0
8
33
2.43
1.54
1.6
1.8
—
—
—
0
0
21
123
1.72
1.51
2.9
1.9
11.1
6.9
u/ml
0.24
21
117
12
58
2.08
1.49
1.8
1.3
—
—
—
0
0
14
72
1.96
1.49
1.4
1.1
—
43.2
—
0
5
9
37
2.44
1.48
1.2
3.2
565.9
726.6
u/ml
—
9
37
9
37
2.44
1.48
1.0
1.1
127.4
142.1
iu/ml
—
9
37
32
211
1.53
1.47
1.3
1.7
—
—
—
0
0
9
38
2.38
1.45
1.0
1.4
—
—
—
0
0
11
52
2.13
1.44
1.2
1.8
0.8
6.1
u/field
0.90
11
38
5
16
3.13
1.44
1.2
1.1
—
—
—
0
0
206
1791
1.18
1.38
5.3
4.2
21.0
20.9
%
0.00
95
840
9
42
2.15
1.34
1.0
2.2
—
—
—
0
0
15
83
1.82
1.31
1.1
2.0
1.5
2.4
u/field
—
10
34
16
91
1.77
1.29
2.1
2.3
—
—
—
0
0
8
34
2.36
1.29
1.4
1.4
—
—
—
0
0
5
18
2.79
1.28
1.0
1.1
89.0
95.2
%
—
5
18
53
397
1.35
1.28
5.8
4.2
24.6
25.0
mmol/l
0.58
48
375
9
44
2.05
1.27
5.2
1.4
—
—
—
0
0
11
56
1.97
1.22
1.1
1.2
—
—
—
0
0
5
19
2.64
1.21
1.0
1.4
—
—
—
0
0
183
1594
1.18
1.21
1.6
1.4
—
—
—
0
0
11
57
1.94
1.17
1.2
1.2
—
—
—
0
0
28
191
1.48
1.14
7.2
3.7
36.8
35.0
umol/l
0.14
23
163
18
112
1.62
1.09
1.8
1.6
—
—
—
0
0
5
21
2.39
1.09
1.0
1.7
1.2
1.2
mmol/l
—
5
21
7
33
2.13
1.05
3.3
1.8
—
1224630.0
—
0
5
62
491
1.28
1.05
1.1
1.0
—
—
—
0
0
7
34
2.07
1.03
1.1
1.1
1573.1
1926.1
miu/ml
—
7
34
9
47
1.92
1.02
1.0
1.2
—
—
—
0
0
9
47
1.92
1.02
1.0
1.2
—
—
—
0
0
27
189
1.44
0.99
2.1
1.6
—
—
—
0
0
35
258
1.37
0.98
1.1
1.1
2.8
7.3
u/ml
—
5
31
18
117
1.55
0.94
1.2
1.2
—
—
—
0
0
13
78
1.67
0.91
1.0
1.1
—
—
u/ml
—
0
0
33
244
1.36
0.91
1.4
1.2
—
—
—
0
0
27
194
1.40
0.89
1.6
1.4
—
—
—
0
0
12
72
1.67
0.85
1.1
1.0
—
—
—
0
0
8
45
1.78
0.84
1.0
1.1
91.6
96.2
u/l
—
8
35
6
33
1.82
0.79
2.2
1.5
—
—
—
0
0
21
148
1.43
0.78
1.0
1.1
—
—
—
0
0
76
641
1.20
0.78
1.2
1.2
139.1
149.6
iu/ml
0.06
27
258
29
218
1.34
0.75
2.3
2.4
55.8
94.4
ug/min
0.53
15
130
7
38
1.85
0.73
1.0
1.1
—
—
—
0
0
16
109
1.47
0.71
1.6
1.9
33.5
32.4
pg
0.51
16
109
43
346
1.25
0.70
2.7
3.2
686.6
4092.2
u/ml
0.60
35
296
5
28
1.79
0.66
1.4
1.0
—
—
—
0
0
5
30
1.67
0.61
3.0
2.9
—
—
—
0
0
5
30
1.67
0.61
3.0
2.9
—
—
—
0
0
13
89
1.47
0.58
1.2
1.3
25901.6
110503.7
e6/l
—
8
50
9
65
1.39
0.50
1.2
1.7
0.8
1.0
g/l
—
9
65
27
332
0.81
0.47
1.5
1.5
—
—
—
0
0
60
525
1.15
0.45
2.9
3.3
47.0
59.3
u/ml
0.23
60
508
11
151
0.73
0.43
2.4
1.7
—
—
—
0
0
124
1140
1.10
0.43
4.4
4.5
33.3
32.6
%
0.31
90
762
140
1297
1.09
0.41
3.1
2.9
0.8
0.8
ug/l
0.01
91
858
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
14
183
0.76
0.40
1.6
1.5
—
—
—
0
0
120
1113
1.09
0.36
7.4
7.0
—
—
—
0
0
6
42
1.43
0.35
1.2
2.1
—
—
—
0
0
15
120
1.25
0.30
1.3
1.1
—
—
—
0
0
71
775
0.91
0.30
1.8
1.7
—
—
—
0
0
14
171
0.82
0.26
1.6
1.5
—
—
—
0
0
14
171
0.82
0.26
1.6
1.5
—
—
—
0
0
14
170
0.82
0.25
1.6
1.5
—
—
—
0
0
14
170
0.82
0.25
1.6
1.5
—
—
—
0
0
14
167
0.84
0.21
1.6
1.5
—
—
—
0
0
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
9.0
—
0
11
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
27
239
1.13
0.21
1.3
1.8
1.8
5.0
iu/l
—
9
81
0
13
0.00
0.21
0.0
1.1
—
33.5
—
0
8
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
21
239
0.88
0.19
1.3
1.5
66.1
262.7
pmol/l
2.03
21
234
16
137
1.17
0.19
1.2
1.0
2.0
2.1
u/ml
—
7
59
31
342
0.90
0.18
1.5
1.4
—
—
—
0
0
10
83
1.21
0.15
1.8
1.7
—
—
—
0
0
10
119
0.84
0.15
1.0
1.0
1.4
1.5
g/l
—
10
109
32
346
0.92
0.13
1.7
1.8
2.4
4.9
mg/l
0.80
24
260
11
96
1.15
0.10
2.0
3.8
—
—
—
0
0
11
125
0.88
0.10
1.4
1.5
—
—
—
0
0
5
45
1.11
0.10
2.8
2.5
—
—
—
0
0
5
47
1.06
0.09
1.8
1.4
—
—
—
0
0
6
57
1.05
0.08
1.2
1.2
9.3
12.0
u/l
—
6
50
18
191
0.94
0.04
3.0
3.6
20.8
26.0
mg/l
0.45
12
126
71
719
0.99
0.01
4.7
2.6
66.8
66.1
ml/min/173m2
0.05
33
293
14
146
0.96
0.00
1.3
1.1
1.4
202.2
iu/ml
—
5
33
12
122
0.98
0.00
1.0
1.0
—
—
—
0
0
31
308
1.01
0.00
1.5
1.4
—
—
—
0
0
23
229
1.00
0.00
1.3
1.4
—
—
—
0
0
6
60
1.00
0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
38.3
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
577.0
—
0
5
7
70
1.00
0.00
1.0
1.1
302.1
290.2
mg/l
—
7
60
0
5
0.00
0.00
0.0
1.0
—
20.9
—
0
5
0
5
0.00
0.00
0.0
1.0
—
142.4
—
0
5
5
57
0.88
0.00
1.2
1.7
7.2
7.1
mmol/l
—
5
33
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
8.0
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_ERYTH_NAS – Other and unspecified erythematous conditions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).